Cell and Gene Manufacturing and Logistics

  1. Data-Driven Manufacturing And Case Management In Autologous Cell Therapy 3/25/2026

    Explore how data-driven manufacturing and end-to-end supply chain orchestration can help cell therapy developers overcome manufacturing challenges, reduce costs, and scale programs more effectively.

  2. To 10X & Beyond, AgentV™-DSP Arrives Ready To Rock 3/25/2026

    Filter fouling has limited exosome therapeutic scalability—until now. Explore how a breakthrough reagent achieves 50% particle recovery versus 5% traditionally, enabling affordable clinical manufacturing.

  3. When Data Blooms: Insights Into MSC-EV Bioprocessing 3/25/2026

    Explore how bone marrow, umbilical cord, and adipose MSCs produce extracellular vesicles with distinct characteristics, and why 3D culture systems consistently outperform 2D platforms in productivity.

  4. EV Content vs. Function: Using Analytical Tools To Reveal The Connection 3/25/2026

    See how downstream processing affects CD73 expression and function on MSC-EVs through orthogonal analytical methods that connect vesicle content to biological activity and therapeutic potential.

  5. Introducing AgentV: A Scalable Solution For 10X Exosome Yield 3/25/2026

    Understand how a downstream treatment prevents filter fouling during exosome purification, enabling 40-70% particle recovery compared to traditional 5-10% yields while maintaining quality attributes.

  6. A Highly Productive, Chemically Defined Exosome Media System 3/24/2026

    Explore how chemically defined media and optimized bioreactor protocols increase exosome yields 40-fold while reducing commercial manufacturing costs from $10,000 to under $1,000 per dose.

  7. Balancing The Scale From The Cellular Bank 3/24/2026

    Understand how early cell banking strategy and manufacturing platform selection influence regulatory timelines, cost structures, and scalability from Phase I through commercial production for MSC therapies.

  8. Get Your Ducks In A Row For GMP Cell Manufacture 3/24/2026

    Uncover strategies to reduce cell bank development from years to months. See how GMP-compliant partnerships eliminate redundant documentation and accelerate your path to first-in-human trials.

  9. MSCs, Exosomes, And Aging 3/24/2026

    Senescent cells spread inflammation and fibrosis across tissues. Learn how MSC-derived exosomes and secreted factors reverse these aging hallmarks by transferring fresh mitochondria and suppressing inflammatory cascades.

  10. Where MSCs Go When Injected And Why It Matters 3/24/2026

    Understand why IV-delivered MSCs undergo rapid apoptosis in lung tissue while locally implanted cells survive as programmable therapeutic factories—and how this knowledge enables rational MSC engineering.